Lars Lindner

from Wikipedia, the free encyclopedia

Lars Hartwin Lindner (* 1972 ) is a German doctor and university lecturer. He is Professor of Oncology at the Ludwig Maximilians University in Munich .

Life

From 1992 to 1999, Lindner studied human medicine at the Georg-August University in Göttingen and the LMU Munich. In the following two years he was an intern at the Großhadern Clinic and received his license to practice medicine in 2001 . In 2002 he received his doctorate at the University of Göttingen with the thesis “Novel cationic lipids with free hydroxyl groups for oligonucleotide and plasmid DNA transfection in the presence of serum” prepared at the Max Planck Institute for Biophysical Chemistry . In 2007 he was recognized as a specialist in internal medicine . From 2008 to 2011 he acquired additional qualifications in palliative medicine , hemostaseology , hematology and internal oncology . In 2008/2009 he completed a postdoc program at the Erasmus University Medical Center as a fellow of the Mildred Scheel Foundation . In 2010 he completed his habilitation in internal medicine with the thesis “Novel thermosensitive liposomes for tumor therapy”. He is also a member of the Advisory Board of the Sarcoma Conference .

Selected publications

  • AA Manzoor x , LH Lindner x , CD Landon, JY Park, AJ Simnick, MR Dreher, S. Das, G. Hanna, W. Park, A. Chilkoti, GA Koning, TL ten Hagen, D. Needham, MW Dewhirst: Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. In: Cancer Res. 72 (21), Nov 1, 2012, pp. 5566-5575.
  • M. Hossann, Z. Syunyaeva, R. Schmidt, A. Zengerle, H. Eibl, RD Issels, LH Lindner: Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. In: J Control Release. 162 (2), Sep 10, 2012, pp. 400-406.
  • LH Lindner, RD Issels: Hyperthermia in soft tissue sarcoma. In: Curr Treat Options Oncol. 12 (1), Mar 2011, pp. 12-20. Review.
  • RD Issels x , LH Lindner x , J. Verweij, P. Wust, P. Reichardt, BC Schem, S. Abdel-Rahman, S. Daugaard, C. Salat, CM Wendtner, Z. Vujaskovic, R. Wessalowski, KW Jauch , HR Dürr, F. Ploner, A. Baur-Melnyk, U. Mansmann, W. Hiddemann, JY Blay, P. Hohenberger; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); European Society for Hyperthermic Oncology (ESHO): Neo-adjuvant chemotherapy alone or with regional hyperthermia for localized high-risk soft-tissue sarcoma: a randomized phase 3 multicentre study. In: Lancet Oncol. 11 (6), Jun 2010, pp. 561-570.
  • LH Lindner x , ME Eichhorn x , H. Eibl, N. Teichert, M. Schmitt-Sody, RD Issels, M. Dellian: Novel temperature-sensitive liposomes with prolonged circulation time. In: Clin Cancer Res. 10 (6), Mar 15, 2004, pp. 2168-2178.
x main authors with equal rights

Web links

Individual evidence

  1. the Advisory Board members of the Sarcoma Conference (as of 2016)  ( page no longer available , search in web archivesInfo: The link was automatically marked as defective. Please check the link according to the instructions and then remove this notice.@1@ 2Template: Dead Link / www.sarkomkonferenz.de